54186-68-4

Basic information

• Product Name: 2,2-dimethyl-5-nitro-1,3-benzodioxole
• Synonyms: 2,2-dimethyl-5-nitro-1,3-benzodioxole
• CAS NO: 54186-68-4
• Molecular Formula: C₉H₉NO₄
• Molecular Weight: 195.17206
• Mol File: 54186-68-4.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 275.6 °C at 760 mmHg
• Flash Point: 125.3 °C
• Appearance: /
• Density: 1.293 g/cm³
• Vapor Pressure: 0.00849mmHg at 25°C
• Refractive Index: 1.553
• CAS DataBase Reference: 2,2-dimethyl-5-nitro-1,3-benzodioxole(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2-dimethyl-5-nitro-1,3-benzodioxole(54186-68-4)
• EPA Substance Registry System: 2,2-dimethyl-5-nitro-1,3-benzodioxole(54186-68-4)

Safety Data

• Hazardous Substances Data: 54186-68-4(Hazardous Substances Data)

Usage

General Description

2,2-dimethyl-5-nitro-1,3-benzodioxole is a chemical compound with the molecular formula C10H11NO5. It is a white to light yellow crystalline solid and is insoluble in water. 2,2-dimethyl-5-nitro-1,3-benzodioxole is commonly used as a synthetic intermediate in the production of pharmaceuticals, fragrances, and dyes. It is also used as a reagent in organic reactions. 2,2-dimethyl-5-nitro-1,3-benzodioxole is known for its ability to undergo nitration reactions, making it a valuable building block for the synthesis of other complex organic compounds. It is important to handle this chemical with caution, as it is potentially harmful if ingested, inhaled, or in contact with skin.

InChI:InChI=1/C9H9NO4/c1-9(2)13-7-4-3-6(10(11)12)5-8(7)14-9/h3-5H,1-2H3

Upstream product

• 120-80-9 benzene-1,2-diol 
• 14005-14-2 2,2-dimethyl-1,3-benzodioxole 
• 860598-63-6 (+/-)-(2-methyl-5-nitro-benzo[1,3]dioxol-2-yl)-acetic acid 
• 3316-09-4 1,2-dihydroxy-4-nitrobenzene 
• 67-64-1 acetone 
• 872823-86-4 3-(2-hydroxy-5-nitro-phenoxy)-crotonic acid 

Downstream Products

• 61963-88-0 N²-cyclohexyl-3-nitro-2-aminopyridine 
• 81864-29-1 N-(2,2-dimethylbenzo[1,3]dioxol-5-yl)acetamide 
• 105780-30-1 1,2-Dinitro-4-hydroxy-5-methoxybenzene 
• 77400-30-7 1,2-dihydroxy-4,5-dinitrobenzene 
• 81864-31-5 2,2-dimethyl-6-nitro-benzo[1,3]dioxol-5-ylamine 
• 7260-32-4 2-ethoxy-5-nitro-phenol 
• 54186-71-9 2,2-dimethyl-5,6-nitro[1,3]benzodioxole 
• 3316-09-4 1,2-dihydroxy-4-nitrobenzene 
• 6324-89-6 2,2-dimethylbenzo[d][1,3]dioxol-5-ylamine 
• 636-93-1 5-nitroguaiacol 

Relevant articles and documents

Class of large ring heterocyclic compound restraining HCV and manufacturing and uses thereof

The invention relates to a class of compounds that inhibit HCV. The compounds are represented by Formula A. The invention also relates to preparation and pharmaceutical use of the compounds.

HETEROCYCLIC HYDRAZIDE DERIVATIVES OF MONOCYCLIC BETA-LACTAM ANTIBIOTICS

Antibacterial activity has been found in compounds of the formula. Compounds having the formula and pharmaceutically acceptable salts thereof, wherein: A is a bond or alkylene; Q completes a 5- or 6-membered saturated or unsaturated(including aromatic) heterocyclic ring having one or two, hetero atoms in the ring selected from nitrogen sulfur or oxygen; X is attached to an available carbon atom in the heterocyclic ring and is hydrogen or oxo; Y is attached to an available carbon atom in the heterocyclic ring and is hydrogen, amino, hydroxyl, halogen, carboxamide, nitrile, or carboxyl, except that Y is not carboxyl when the bicyclic ring completed by Q is 2-quinolyl, 3-quinolyl, or quinoxalyl; and the remaining symbols are as defined in the specification

Imidazole derivatives

Tricyclic imidazole derivatives of the formula STR1 wherein R1 is 2-pyridyl optionally substituted by lower alkyl or lower alkoxy, n is the integer 0 or 1, R2 is hydrogen or lower alkyl, R3 and R4, independently, are hydrogen or lower alkyl, A is a group of the formula STR2 m is the integer 2 or 3, R5, R6, R7 and R8, independently, are hydrogen or lower alkyl, and R9 is hydrogen and R10 is hydrogen or lower alkyl or R9 and R10 taken together are oxo, provided that at least one of R3 and R4 is lower alkyl when A is a group of the formula and their pharmaceutically acceptable acid addition salts. The compounds of formula I inhibit gastric acid secretion and prevent the formation of gastric ulcers.